We observed frequent downregulation of SPAG6 and L1TD1 mRNA expression in primary tumor ﻿(TU) samples compared to corresponding non-malignant lung tissue (NL) samples of NSCLC patients. This evidence concerns the gene SPAG6 and neoplasm.